The prediction value of platelet-derived growth factor for major adverse cardiovascular events in patients with acute non-ST-segment elevation myocardial infarction-Reference-Cited by-同舟云学术

The prediction value of platelet-derived growth factor for major adverse cardiovascular events in patients with acute non-ST-segment elevation myocardial infarction

Published:2023-03-13 Issue:1 Volume:55 Page:1047-1057
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Liang Yan¹,Wang Jing-xian¹,Wu Xiao-Yuan¹,Cui Yan¹,Zou Zhong-He¹,Li Wen-Qing¹,Liu Yin²,Gao Jing¹³⁴

Affiliation:

1. Thoracic Clinical College, Tianjin Medical University, Tianjin, P.R. China

2. Department of Cardiology, Tianjin Chest Hospital, Tianjin, P.R. China

3. Cardiovascular Institute, Tianjin Chest Hospital, Tianjin, P.R. China

4. Tianjin Key Laboratory of Cardiovascular Emergency and Critical Care, Tianjin Municipal Science and Technology Bureau, Tianjin, P.R. China

Funder

Tianjin Health Research

Key Project of Scientific and Technological Support Plan of Tianjin in 2020

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2023.2176542

Reference30 articles.

1. Anti-Inflammation Relieving Heart Dysfunction and Depressive Behaviors of Mice Under Myocardial Infarction and Chronic Stress

2. Diagnosis and Treatment of Acute Coronary Syndromes

3. Ticagrelor or Prasugrel in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

4. Staged revascularization for chronic total occlusion in the non-IRA in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: an updated systematic review and meta-analysis;Geng Y;Cardiovasc Innovat Appl,2022

5. Correlation between the Serum Platelet-Derived Growth Factor, Angiopoietin-1, and Severity of Coronary Heart Disease

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Genetic Risk Score with Variants at PDGFs and PDGFRB for the Risk of Major Cardiovascular Adverse Events in Patients with Coronary Artery Disease;2024-05-10